Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer

BACKGROUND: Patients with locally advanced and high-risk prostate cancer (LAPC) are prone to experience biochemical recurrence despite radical prostatectomy (RP). We evaluated feasibility, safety and activity of a neoadjuvant chemohormonal therapy (NCHT) with 3-weekly full dose docetaxel and complet...

Descripción completa

Detalles Bibliográficos
Autores principales: Thalgott, Mark, Horn, Thomas, Heck, Matthias M, Maurer, Tobias, Eiber, Matthias, Retz, Margitta, Autenrieth, Michael, Herkommer, Kathleen, Krause, Bernd J, Gschwend, Jürgen E, Treiber, Uwe, Kübler, Hubert R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974001/
https://www.ncbi.nlm.nih.gov/pubmed/24598155
http://dx.doi.org/10.1186/1756-8722-7-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974001/
https://www.ncbi.nlm.nih.gov/pubmed/24598155
http://dx.doi.org/10.1186/1756-8722-7-20

Ejemplares similares